tDCS, Moral Decision-Making, fMRI

The Role of Implicit Attitude in the tDCS Modulation on Moral Decision-Making

Morality is the social rule about appropriateness of the behavior, containing concepts of justice, fairness, and rights. Previous studies suggested that the activation of right temporoparietal junction (rTPJ) should be involved in mental state reasoning in moral cognition. Implicit moral attitude, which reflects people's fundamental beliefs about right and wrong, could be assessed by implicit association test on moral scenarios (mIAT), as indicated by the D scores. According to our previous findings, we postulate that, during moral decision-making, the high D group would have less rTPJ involvement and the low D group would have more. Here we applied tDCS, a non-invasive neuromodulation technique, to modulate cortical excitability in rTPJ.

Based on our postulation, we divided participants into high D and low D group and hypothesized that tDCS over rTPJ would modulate the behavior depending on the group. The results revealed that, in aspect of mIAT, implicit moral attitude could be modulated differently depending on the group via tDCS over rTPJ. In addition, hemodynamic response within rTPJ showed a main effect of tDCS while carrying out the helping behavior. In conclusion, these findings indicated that tDCS over rTPJ could modulate the implicit moral attitude as well as the rTPJ activity during moral action.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

42

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Forty-two healthy volunteers (20 male; 22 female) without any history of psychiatry or neurological disorders (e.g., dementia, seizures), head injury, and alcohol or substance abuse, are all ethnic Chinese, right-handed, and aged between 20 to 30 years old (M = 23.476, SD = 2.211). They were recruited via the online survey sent to the student social group of National Yang-Ming University and National Taiwan University. Additionally, the study was approved by National Yang-Ming University Hospital, Yilan, Taiwan (IRB: 2016B008).

Description

Inclusion Criteria:

  • healthy volunteers, are all ethnic Chinese, right-handed, and aged between 20 to 30 years old

Exclusion Criteria:

  • any history of psychiatry or neurological disorders (e.g., dementia, seizures), head injury, and alcohol or substance abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
anodal
For the active stimulation, which are anodal and cathodal tDCS, a constant current of 1 mA was delivered through 35 cm2 electrode for 20 minutes with fade-in and fade-out of 10 seconds, producing a current density of 0.029 mA/cm2. During anodal tDCS, the anode was placed over right temporoparietal junction, and the cathode was placed over left supraorbital area.
In the present study, we applied DC Brain Stimulator Plus to stimulate right temporoparietal junction (rTPJ). The target electrode was placed over the location of rTPJ; on the other hand, the return electrode was placed over the left supraorbital area. That is, during anodal tDCS, the anode was placed over CP6, and the cathode was placed over left supraorbital area; conversely, during cathodal tDCS, the cathode was placed over CP6, and the anode was placed over left supraorbital area. For the active stimulation, which are anodal and cathodal tDCS, a constant current of 1 mA was delivered through 35 cm2 electrode for 20 minutes with fade-in and fade-out of 10 seconds, producing a current density of 0.029 mA/cm2. On the other hand, same fade-in, fade-out, and current density were applied for the sham stimulation, but the duration of current-delivering only last 35 seconds. Therefore, participants could feel the skin sensation but did not have the after-effects of tDCS.
cathodal
For the active stimulation, which are anodal and cathodal tDCS, a constant current of 1 mA was delivered through 35 cm2 electrode for 20 minutes with fade-in and fade-out of 10 seconds, producing a current density of 0.029 mA/cm2. During cathodal tDCS, the cathode was placed over right temporoparietal junction, and the anode was placed over left supraorbital area.
In the present study, we applied DC Brain Stimulator Plus to stimulate right temporoparietal junction (rTPJ). The target electrode was placed over the location of rTPJ; on the other hand, the return electrode was placed over the left supraorbital area. That is, during anodal tDCS, the anode was placed over CP6, and the cathode was placed over left supraorbital area; conversely, during cathodal tDCS, the cathode was placed over CP6, and the anode was placed over left supraorbital area. For the active stimulation, which are anodal and cathodal tDCS, a constant current of 1 mA was delivered through 35 cm2 electrode for 20 minutes with fade-in and fade-out of 10 seconds, producing a current density of 0.029 mA/cm2. On the other hand, same fade-in, fade-out, and current density were applied for the sham stimulation, but the duration of current-delivering only last 35 seconds. Therefore, participants could feel the skin sensation but did not have the after-effects of tDCS.
sham (as a control condition)
same fade-in, fade-out, and current density were applied for the sham stimulation, but the duration of current-delivering only last 35 seconds.
In the present study, we applied DC Brain Stimulator Plus to stimulate right temporoparietal junction (rTPJ). The target electrode was placed over the location of rTPJ; on the other hand, the return electrode was placed over the left supraorbital area. That is, during anodal tDCS, the anode was placed over CP6, and the cathode was placed over left supraorbital area; conversely, during cathodal tDCS, the cathode was placed over CP6, and the anode was placed over left supraorbital area. For the active stimulation, which are anodal and cathodal tDCS, a constant current of 1 mA was delivered through 35 cm2 electrode for 20 minutes with fade-in and fade-out of 10 seconds, producing a current density of 0.029 mA/cm2. On the other hand, same fade-in, fade-out, and current density were applied for the sham stimulation, but the duration of current-delivering only last 35 seconds. Therefore, participants could feel the skin sensation but did not have the after-effects of tDCS.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Justice Sensitivity Inventory
Time Frame: 10 minutes
Justice Sensitivity Inventory (JSI) is a self-report questionnaire which consists of four perspectives of justice sensitivity: victim, observer, beneficiary, and perpetrator (Schmitt, Baumert, Gollwitzer, & Maes, 2010; Schmitt, Gollwitzer, Maes, & Arbach, 2005). Each perspective contains ten descriptions, and participants would answer on a scale ranging from 1 (not at all) to 7 (exactly). Justice sensitivity reflects how people react to injustice and can be used to predict justice-related emotion and behavior (Baumert, Rothmund, Thomas, Gollwitzer, & Schmitt, 2013).
10 minutes
Morality Implicit Association Test
Time Frame: 15 minutes
Implicit moral attitude was assessed by morality implicit association test (mIAT) in present study. The test was adapted from Implicit Association Test (IAT) developed by Greenwald and colleagues (1998). It measures the strength of the association 10 between target concepts and their associated attributes. In mIAT, target concepts were presented by morally good and morally bad clips, and attributes were presented by positive and negative words.
15 minutes
Moral Action Task
Time Frame: 10 minutes

To verify the modulation of rTPJ activity via tDCS and to examine whether this modulation would alter people's moral behavior, participants would take the perspective of the active role while viewing moral scenarios in the MRI scanner.

Forty-five dynamic visual stimuli from previous research were validated and applied in the Moral Action Task. Each animation consists of three still images with the respective duration of 1000ms, 200ms, and 200ms. These animations contain three kinds of moral scenarios: (1) a person who is taking an action to physically harm one another (perpetrating behavior); (2) a person who is alleviating the physical pain which the other one is suffered (helping behavior); and (3) a person who is carrying out an action that irrelevant to the other one (neural behavior). Additionally, the protagonists in these scenarios were all acting without the presence of faces, and therefore the participants would have no emotional clues for these social interactions.

10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Moral Evaluation: Rating of Moral Action Task
Time Frame: 5 minutes
Outside the MRI scanner, participants carried out the Moral Action Task again. They were instructed to imagine themselves as the actor in the animation and pressed the button just like they really did the moral actions. Moreover, they were asked how much guilt or warm-glow after doing the action. The ratings were on a visual analog scale ranging from 1 to 7 points (Yoder & Decety, 2014).
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 27, 2016

Primary Completion (Actual)

November 30, 2019

Study Completion (Actual)

December 10, 2020

Study Registration Dates

First Submitted

December 18, 2020

First Submitted That Met QC Criteria

December 18, 2020

First Posted (Actual)

December 23, 2020

Study Record Updates

Last Update Posted (Actual)

December 23, 2020

Last Update Submitted That Met QC Criteria

December 18, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2016B008

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Morality

Clinical Trials on transCranial direct current stimulation

Subscribe